Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 243

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part II, Item 6
Chunk 243
---
    2025-03-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-03-31

    0002028614
    
      us-gaap:RetainedEarningsMember

    2025-03-31

    0002028614

    2025-03-31

    0002028614
    
      us-gaap:CommonStockMember

    2025-04-01
    2025-06-30

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-04-01
    2025-06-30

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-04-01
    2025-06-30

    0002028614
    
      us-gaap:RetainedEarningsMember

    2025-04-01
    2025-06-30

    0002028614

    2025-04-01
    2025-06-30

    0002028614
    
      us-gaap:CommonStockMember

    2025-06-30

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-06-30

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-06-30

    0002028614
    
      us-gaap:RetainedEarningsMember

    2025-06-30

    0002028614

    2025-06-30

    0002028614
    
      us-gaap:CommonStockMember

    2025-07-01
    2025-09-30

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-07-01
    2025-09-30

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-07-01
    2025-09-30

    0002028614
    
      us-gaap:RetainedE